Abstract:Background: We recently found that circular RNA- gamma -secretase-activating protein (circGSAP) down-regulation in peripheral blood mononuclear cells was associated with the occurrence and outcomes of idiopathic pulmonary arterial hypertension (IPAH). We aimed to demonstrate that the underlying mechanisms of circGSAP regulate pulmonary microvascular endothelial cells (PMECs) dysfunction by absorbing microRNA to inhibit target genes in IPAH.Methods: Quantitative real-time polymerase chain reaction, immunofluorescence staining, Cell Counting Kit-8, Calcein-AM/PI staining and Transwell and dual-luciferase reporter assays were used to clarify the roles of circGSAP.Findings: CircGSAP levels were decreased in the plasma of patients with IPAH and were associated with poor outcomes. In monocrotaline-induced PH rats, circGSAP overexpression decreased mortality, and improved pulmonary vascular remodelling and right ventricular remodelling. CircGSAP overexpression inhibited hypoxia-induced PMECs proliferation, migration and mortality by absorbing miR-27a-3p. BMPR2 was identified as a miR-27a-3p target gene. BMPR2 levels were up-regulated in PMECs treated with circGSAP plasmid and down-regulated in hypoxia-treated PMECs. The effects of small interfering RNA (siRNA) circGSAP on PMECs proliferation, migration and mortality were mitigated via a miR-27a-3p inhibitor. Similarly, siRNA BMPR2 ameliorated the effect of the miR-27a-3p inhibitor on PMECs proliferation and migration.Interpretation: Our findings demonstrated that down-regulated circGSAP facilitates PMECs dysfunction by competitively binding with miR- 27a-3p leading to decreased BMPR2 expression, indicating potential therapeutic strategies for IPAH.Funding Information: This work was supported by funding from theProgram of National Natural Science Foundation of China (81870042, 81700045, and 81900050) and Program of Natural Science Foundation of Shanghai (21ZR1453800, 201409004100 and 18ZR1431500).Declaration of Interests: None.Ethics Approval Statement: This study was approved and supervised by the Ethics Committee of Shanghai Pulmonary Hospital (number: K20-150Y). Written informed consent was obtained from all participants. The experiments conformed to the Guide for the Care and Use of Laboratory Animals of the Institute for Laboratory Animal Research at the Experimental Animal Centre of Tongji University, Shanghai, China.

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension

CircGSAP Alleviates the Dysfunction of Pulmonary Microvascular Endothelial Cells via BMPR2&nbsp;Signalling Pathway

The Role of TGF-β or BMPR2 Signaling Pathway-Related Mirna in Pulmonary Arterial Hypertension and Systemic Sclerosis

Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction.

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.

CircPMS1 Promotes Proliferation of Pulmonary Artery Smooth Muscle Cells, Pulmonary Microvascular Endothelial Cells, and Pericytes under Hypoxia.

CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis

Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis

CircATP2B4 promotes hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the miR-223/ATR axis

CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension

MicroRNA‐483 Amelioration of Experimental Pulmonary Hypertension

CircHSPG2 knockdown attenuates hypoxia-induced apoptosis, inflammation, and oxidative stress in human AC16 cardiomyocytes by regulating the miR-1184/MAP3K2 axis

Circ-calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats

MicroRNA-663 Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting TGF-β1/smad2/3 Signaling

The HIF-1 alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy

Hsa_circwdr37_016 Regulates Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells

CircNAP1L4 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation Via the NAP1L4-mediated Super- Enhancerdriven Glycolysis Gene Hexokinase II (HK II) in Pulmonary Hypertension

miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension